Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
Clinical trial NCT00244829 · COMPLETED
Trial details
- NCT number
- NCT00244829
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.